Navigation Links
Talecris Biotherapeutics to Report First Quarter 2010 Financial Results
Date:4/26/2010

RESEARCH TRIANGLE PARK, N.C., April 26 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) will release its first quarter 2010 financial results on April 28, 2010, after the stock market closes and will host a conference call at 8:30 a.m. Eastern Time on April 29, 2010.

Investors and analysts may participate via phone by calling 1-888-713-4205 (domestic) or 1-617-213-4862 (international), pass code number 21563385. To ensure timely access, please dial into the call approximately 10 minutes before it is scheduled to begin. The listen-only webcast will also be available through the investor relations section of http://www.talecris.com.

Participants may pre-register for the conference call at: https://www.theconferencingservice.com/prereg/key.process?key=PPMXLQM7G. Pre-registrants will be issued a PIN number to use when dialing into the live call, which will provide quick access to the conference by bypassing the operator upon connection.

A replay of the conference call will be available beginning approximately two hours after the call concludes and will remain accessible until May 6, 2010, by dialing 1-888-286-8010 (domestic) or 1-617-801-6888 (international), pass code number 40214869. The webcast of the conference call will be archived on the investor relations section of http://www.talecris.com.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas, including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com.


'/>"/>
SOURCE Talecris Biotherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Siemens/Talecris Win Best Partnership in the Outsourcing Excellence Awards
2. Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics
3. The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
4. CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
5. Oxygen Biotherapeutics, Inc. Outlines Plans for New Products During Investor Conference Presentation
6. Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors
7. Oxford BioTherapeutics Appoints Michael Moore as Chairman
8. Oxygen Biotherapeutics, Inc. Expands Board of Directors
9. New Oxygen Biotherapeutics, Inc. Investor Presentation Available on Company Website
10. Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Report
11. Oxygen Biotherapeutics, Inc. Seeks Shareholder Approval for Reverse Stock Split
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... Md. , Feb. 21, 2017 Synthetic Biologics, ... designed to preserve the microbiome to protect and restore the health ... the year ended December 31, 2016 on Thursday, March 2, 2017, ... p.m. EST. The dial-in information for the call is as follows: ... ...
(Date:2/21/2017)... PARK, CA (PRWEB) , ... February 21, 2017 ... ... of the VTX-1 Liquid Biopsy System , a fully automated benchtop system ... microfluidic technology. The VTX-1 is being launched at the Molecular Medicine Tri Conference ...
(Date:2/21/2017)... , ... February 21, 2017 , ... The medical potential ... their use, in multiple areas of medicine, due to their differentiating characteristics. Stem cells ... they have the ability to be induced to become tissue or organic-specific cells with ...
(Date:2/21/2017)... ... February 21, 2017 , ... Creation Technologies, a ... for original equipment manufacturers (OEMs) , today announced it has received the ‘Highest ... year winning in its category of electronics manufacturing services (EMS) providers with annual ...
Breaking Biology Technology:
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, ... therapies for the treatment of bacterial infections, today ... of antibacterial candidates from Pro Bono Bio Ltd ... prevalence of multi-drug resistant forms of Gram-negative bacteria.  ... Anti Infectives Ltd, a PBB group company. ...
(Date:1/24/2017)... 2017 Biopharm Reports has carried out ... of nuclear magnetic resonance spectroscopy (NMR). This involved ... current practices, developments, trends and end-user plans over ... and opportunities. These areas include growth in the ... and innovation requirements, hyphenated NMR techniques, main suppliers ...
(Date:1/19/2017)... 19, 2017 Sensory Inc ., ... security for consumer electronics, and i ... and cybersecurity solutions, today announced a global partnership ... institutions worldwide to bolster security of data sensitive ... user authentication platforms they offer, innerCore now offers ...
Breaking Biology News(10 mins):